Antipsychotic Drugs Market- Booming Trend in Pharmaceutical Industry by 2024
Global Antipsychotic Drugs Market: OverviewThe global market for antipsychotic drugs is witnessing significant traction owing to the global rise in prevalence of psychotic disorders such as bipolar disorder, schizophrenia, delusions, hallucinations, and very severe depression (called “psychotic depression”). Recent studies have stated that antipsychotics are one of the top-selling and most widely prescribed drugs for managing psychotic conditions in the United States. Although earlier prescribed only for such psychotic conditions, a vast variety of antipsychotics are also prescribed as a supplement to antidepressant medications and for routine complaints such as insomnia. Records demonstrate that antipsychotics such as Abilify are outselling other drug varieties and are becoming one of the key and high-profit drug classes of the pharma industry.
This report on the global antipsychotic drugs market presents a thorough overview of the present state of the market, growth dynamics and popular trends of the past years, and predictions regarding the course of growth the market will witness over the period between 2016 and 2024. The report gives in-depth insights about the factors that will have the most influence on the market’s future growth prospects, including market drivers, restraints, regulatory landscape, and competition among key players.
Download the Industry Fact Sheet by 2024
https://goo.gl/j1hVZL
A thorough account of the vendor and competitive landscape of the global antipsychotic drugs market included in the report sheds light on the various opportunities available for new and existing players to gain promising returns on investment in the field of antipsychotic drugs. A SWOT analysis of key vendors allows a clear understanding of the strengths and weaknesses of key market vendors as well as the threats and opportunities ahead of these companies in the global market.
Global Antipsychotic Drugs Market: Drivers and Restraints
Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This translates into a potential market of about 7.5 mn people as target consumers for antipsychotic drugs. Although the potential consumer base for the market is relatively much smaller than that for diseases such as cancer and diabetes, the high costs of antipsychotic drugs make the market one with promising returns. The market holds immense growth promise for future years as the patient pool of psychotic conditions rises at an alarming rate across the globe. The introduction of newer antipsychotic compounds and the vast funds poured in for research and development activities are also expected to have a significant positive impact on the overall development of the market in the near future.
However, the market is expected to bear the brunt of the concerning rise in cases of over prescription of these drugs even for routine complaints such as insomnia and the increased awareness regarding the severe drawbacks as well as chances of addiction associated with these drugs. The issues have been known to be more intense in developed economies such as North America and a significant rise in strict regulations observing stronger control on the prescription of these drugs and misleading advertisements has been seen in the past few years. The impending patent expirations of several blockbuster drugs and the threat of cheap generics is also adding to worries of companies operating in the global antipsychotic drugs market.
Browse the full Global strategic Business report:
http://www.transparencymarketresearch.com/antipsychotic-drugs-market.html
Global Antipsychotic Drugs Market: Segmentation
The report segments the global antipsychotic drugs market on the basis of criteria such as drug classes, target disease, and geography.
On the basis of drug classes, the global antipsychotic drugs market is commonly segmented into: older or first-generation antipsychotics, also called typical antipsychotics or neuroleptics, and newer or second-generation drugs, also called as atypical antipsychotics. Studies have shown that several atypical antipsychotics are useful for a broader spectrum of conditions than older or typical antipsychotics and mostly help treat conditions such as bipolar depression that have not responded to standard medication alone.
The key target diseases for the antipsychotic drugs market are Schizophrenia, psychotic depression, dementia, and bipolar disorder. Of these, Schizophrenia and psychotic depression are expected to account for the dominant share in the market’s revenues over the report’s forecast period. Of the key regional markets analyzed, North America is presently the dominant consumer of antipsychotic drugs and is expected to remain a key regional market owing to the vast and rising patient pool of psychotic disorders.
Some of the key companies operating in the global antipsychotic drugs market are Johnson & Johnson, Pfizer, Eli Lilly and Co., Bristol-Myers Squibb, AstraZeneca, and GlaxoSmithKline
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: mailto:sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antipsychotic Drugs Market- Booming Trend in Pharmaceutical Industry by 2024 here
News-ID: 415795 • Views: …
More Releases from TMR – Research Reports
Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home…
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture.
Another factor catalyzing growth in the global…
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.…
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units.
While expanding operations across emerging nations has…
More Releases for Antipsychotic
Market Analysis: Antipsychotic Drugs Market on the Rise
The schizophrenia segment emerged dominant in the global antipsychotic drugs market in 2018. The segment had acquired an astonishing 45.2% of the global antipsychotic drugs market share in the same year owing to the rising prevalence of the disorder. This information is published in a report by Fortune Business Insights, titled, "Antipsychotic Drugs: Global Market Analysis, Insights and Forecast, 2019-2026." According to the report, the global market was worth US$…
Market Analysis: Antipsychotic Drugs Market on the Rise
The schizophrenia segment emerged dominant in the global antipsychotic drugs market in 2018. The segment had acquired an astonishing 45.2% of the global antipsychotic drugs market share in the same year owing to the rising prevalence of the disorder. This information is published in a report by Fortune Business Insights, titled, "Antipsychotic Drugs: Global Market Analysis, Insights and Forecast, 2019-2026." According to the report, the global market was worth US$…
Antipsychotic Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Antipsychotic Medications market.
Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-antipsychotic-medications-market_p103541.html
Global Antipsychotic Medications Market: Forecast by Type / Application / Region
The worldwide market for Antipsychotic Medications is expected to…
Antipsychotic Drugs Market, by Drug Type, Application, Distribution Channel
Anti-psychotic drugs, also called tranquilizers or neuroleptics, are a specific type of medication that are majorly used for the treatment of schizophrenia or bipolar disorder. They are used to manage psychosis, including hallucinations, delusions, and disordered thought of paranoia, among others. Anti-psychotic drugs are effective for the treatment of psychosis in a short duration. These drugs block the dopamine receptors in the dopaminergic pathways of the brain, thereby repressing the…
Antipsychotic Drugs Market Enhancement in Medical Sector 2025
This report studies the global Antipsychotic Drugs market, analyzes and researches the Antipsychotic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline
…
Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/100987
Market segment by Regions/Countries, this report covers
United States,EU,Japan,China,India,Southeast Asia
Market segment by Type, the product can…
Global Antipsychotic Drugs Market Size, Status and Forecast 2025
This report studies the global Antipsychotic Drugs market, analyzes and researches the Antipsychotic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline
...
Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/100987
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, the product can…